Name | Number of supported studies | Average coverage | |
---|---|---|---|
neuron | 5 studies | 24% ± 8% | |
glutamatergic neuron | 5 studies | 35% ± 22% | |
retinal ganglion cell | 4 studies | 46% ± 21% | |
GABAergic neuron | 3 studies | 39% ± 12% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 30% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 5912.57 | 2633 / 2642 | 96% | 23.87 | 675 / 705 |
pancreas | 100% | 3077.77 | 328 / 328 | 49% | 2.01 | 87 / 178 |
stomach | 75% | 870.41 | 271 / 359 | 43% | 2.37 | 124 / 286 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.06 | 1 / 1 |
intestine | 30% | 191.26 | 292 / 966 | 47% | 2.82 | 247 / 527 |
prostate | 2% | 8.19 | 5 / 245 | 68% | 4.23 | 342 / 502 |
eye | 0% | 0 | 0 / 0 | 68% | 4.58 | 54 / 80 |
adrenal gland | 1% | 12.26 | 3 / 258 | 58% | 6.13 | 133 / 230 |
heart | 31% | 173.98 | 268 / 861 | 0% | 0 | 0 / 0 |
ovary | 0% | 0 | 0 / 180 | 28% | 1.22 | 121 / 430 |
breast | 3% | 14.67 | 13 / 459 | 20% | 0.75 | 226 / 1118 |
esophagus | 5% | 25.89 | 75 / 1445 | 16% | 0.63 | 29 / 183 |
bladder | 0% | 0 | 0 / 21 | 19% | 0.92 | 96 / 504 |
uterus | 0% | 0 | 0 / 170 | 16% | 0.70 | 75 / 459 |
lung | 0% | 0 | 0 / 578 | 13% | 0.52 | 148 / 1155 |
skin | 0% | 0.25 | 1 / 1809 | 10% | 0.40 | 46 / 472 |
adipose | 7% | 39.64 | 82 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 4% | 0.37 | 2 / 45 |
kidney | 0% | 0 | 0 / 89 | 3% | 0.08 | 23 / 901 |
liver | 0% | 0 | 0 / 226 | 2% | 0.11 | 10 / 406 |
thymus | 0% | 0.60 | 1 / 653 | 2% | 0.03 | 13 / 605 |
blood vessel | 1% | 2.98 | 9 / 1335 | 0% | 0 | 0 / 0 |
muscle | 1% | 3.10 | 5 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
GO_0007266 | Biological process | Rho protein signal transduction |
GO_0032880 | Biological process | regulation of protein localization |
GO_0007162 | Biological process | negative regulation of cell adhesion |
GO_0001835 | Biological process | blastocyst hatching |
GO_0005829 | Cellular component | cytosol |
GO_0005886 | Cellular component | plasma membrane |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0016020 | Cellular component | membrane |
GO_0005094 | Molecular function | Rho GDP-dissociation inhibitor activity |
GO_0005515 | Molecular function | protein binding |
GO_0005096 | Molecular function | GTPase activator activity |
Gene name | ARHGDIG |
Protein name | Rho GDP dissociation inhibitor (GDI) gamma Rho GDP-dissociation inhibitor 3 (Rho GDI 3) (Rho-GDI gamma) HCG1985507, isoform CRA_a (Rho GDP-dissociation inhibitor 3) Rho GDP dissociation inhibitor gamma Rho GDP dissociation inhibitor (GDI) gamma (Rho GDP dissociation inhibitor gamma) |
Synonyms | LA16c-314G4.1-002 LA16c-314G4.1-004 LA16c-314G4.1-005 LA16c-314G4.1-006 hCG_1985507 |
Description | FUNCTION: Inhibits GDP/GTP exchange reaction of RhoB. Interacts specifically with the GDP- and GTP-bound forms of post-translationally processed Rhob and Rhog proteins, both of which show a growth-regulated expression in mammalian cells. Stimulates the release of the GDP-bound but not the GTP-bound RhoB protein. Also inhibits the GDP/GTP exchange of RhoB but shows less ability to inhibit the dissociation of prebound GTP. |
Accessions | A2ID99 A2IDA1 ENST00000447871.5 C9J3B5 Q4TT68 Q99819 F1T0H7 A2IDA0 ENST00000414650.1 ENST00000219409.8 |